Israel Englander’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.77M Buy
106,248
+22,989
+28% +$1.58M ﹤0.01% 2565
2026
Q1
$5.32M Sell
83,259
-101,520
-55% -$7.05M ﹤0.01% 2866
2025
Q4
$14.7M Buy
184,779
+23,779
+15% +$2.01M 0.01% 1875
2025
Q3
$10.6M Buy
161,000
+139,407
+646% +$8.29M ﹤0.01% 2331
2025
Q2
$1.14M Sell
21,593
-86,906
-80% -$4.08M ﹤0.01% 4308
2025
Q1
$5.39M Buy
108,499
+100,620
+1,277% +$5.59M ﹤0.01% 2788
2024
Q4
$500K Buy
+7,879
New +$456K ﹤0.01% 4751
2024
Q1
Sell
-20,697
Closed -$1.34M 6412
2023
Q4
$1.2M Buy
+20,697
New +$1.06M ﹤0.01% 4012
2023
Q2
Sell
-22,107
Closed -$468K 6386
2023
Q1
$468K Buy
22,107
+7,346
+50% +$164K ﹤0.01% 4649
2022
Q4
$294K Buy
14,761
+3,343
+29% +$166K ﹤0.01% 5122
2022
Q3
$562K Sell
11,418
-13,987
-55% -$660K ﹤0.01% 4861
2022
Q2
$1.29M Buy
25,405
+7,532
+42% +$333K ﹤0.01% 4141
2022
Q1
$745K Buy
17,873
+962
+6% +$50.4K ﹤0.01% 4796
2021
Q4
$1.48M Sell
16,911
-2,913
-15% -$285K ﹤0.01% 4049
2021
Q3
$2.4M Buy
19,824
+11,299
+133% +$1.54M ﹤0.01% 3697
2021
Q2
$1.66M Sell
8,525
-2,476
-23% -$814K ﹤0.01% 4178
2021
Q1
$4.47M Buy
+11,001
New +$4.91M ﹤0.01% 2699

Other funds holding IRON

Israel Englander's IRON Position: Q2 2026 in Review

Israel Englander increased its Disc Medicine (IRON) stake by 28% in Q2 2026, buying an estimated $1.58M and bringing the position to 106,248 shares worth $7.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2565.

Israel Englander first reported a position in IRON in Q1 2021 and has held it in 17 quarters since. The position peaked at $14.7M in Q4 2025. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Israel Englander held 106,248 shares of Disc Medicine worth $7.77M as of Q2 2026.
  • Israel Englander bought 22,989 Disc Medicine shares in Q2 2026, an estimated $1.58M.
  • Disc Medicine made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2565 holding.
  • Israel Englander first reported a position in Disc Medicine in Q1 2021 and has held it in 17 quarters since.
  • Israel Englander's Disc Medicine position peaked at $14.7M in Q4 2025.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.